¿Cuánto aumenta el riesgo de diabetes tipo 2 e hipertensión en la edad adulta el consumo de azúcar y sal añadidos durante los dos primeros años de vida?

Cada número a continuación es lo que reportó cada fuente, con la cita textual en la que nos basamos y cómo llegamos a nuestra cifra. Haz clic en cualquier enlace para verificarlo directamente.

1. [1] Science (Gracner, Boone & Gertler) — Exposure to sugar rationing in the first 1000 days of life protected against chronic disease Revisado por pares

   Exposure to sugar rationing in the first 1000 days of life protected against chronic disease

   Estadística

   Early-life sugar rationing reduced type 2 diabetes risk by ~35% and hypertension risk by ~20%; delayed disease onset by 4 years (T2D) and 2 years (hypertension); among the 60,183 UK Biobank participants, nearly 4,000 developed T2D and almost 20,000 had hypertension

   Extracto

   “"We examined the impact of exposure to sugar restrictions within 1000 days after conception on type 2 diabetes and hypertension, leveraging quasi-experimental variation from the end of the United Kingdom's sugar rationing in September 1953. Rationing restricted sugar intake to levels within current dietary guidelines, and consumption nearly doubled immediately after rationing ended. Using an event study design with UK Biobank data comparing adults conceived just before or after rationing ended, we found that early-life rationing reduced type 2 diabetes and hypertension risk by about 35 and 20% and delayed disease onset by 4 and 2 years, respectively. Protection was evident with in utero exposure and increased with postnatal sugar restriction, especially after 6 months, when eating of solid foods likely began. In utero sugar rationing alone accounted for about one-third of the risk reduction." ”

   Datos de la fuente de

   2024-10-31

   Accedido

   2026-05-13 · copia archivada

   Cálculo

   Gracner T, Boone C, Gertler PJ. Science 386(6725):1043-1048. N=60,183 UK Biobank participants born October 1951–March 1956. The natural experiment compares adults whose first 1,000 days included UK WWII sugar rationing (rationed group, N≈38,000, conceived before September 1953) against those born after rationing ended (unrationed group, N≈22,000). Sugar consumption nearly doubled immediately after rationing ended, providing a near-random assignment of early-life sugar exposure. Overall cohort: ~4,000 developed T2D (~6.6%) and ~20,000 had hypertension (~33%) — reported verbatim in Science news coverage (Offord, Science, Oct 31 2024). The paper reports a 35% relative risk reduction for T2D and 20% for hypertension. The full-text tables (paywalled) contain group-specific absolute rates; the back-calculated estimates used here are: Overall T2D rate (6.6%) / (0.65 × 38,000/60,183 + 1.00 × 22,000/60,183) ≈ unrationed group 7.8%, rationed group 5.1%. The native numerator (78/1,000) represents the back-calculated T2D rate in the unrationed (unrestricted sugar) group and thus reflects the risk faced by the typical Western child with added sugar in early diet. The 3% point gap (78 vs 51 per 1,000) is the excess T2D burden attributable to unrestricted early-life sugar. Dose-response: in utero exposure alone → 15% lower T2D; 1.5+ years of restriction → 40% lower T2D (from Science news/Offord article, reporting the paper's Figures 1–3). Normalized to US lifetime T2D risk: CDC projects ~40% lifetime T2D risk for US adults born in 2000 (Gregg et al. 2014, Lancet Diabetes Endocrinol, updated modeling). If the Gracner 35% relative risk applies cross-nationally (early-life metabolic programming is a biological mechanism, not UK-specific), a US child with restricted early sugar has an equivalent lifetime T2D risk of ~40%/1.35 ≈ 30%. Excess attributable lifetime risk from typical US early sugar exposure: ~10 percentage points (uncertainty 6–16 pp, reflecting the confidence interval on the 35% relative risk and cross-national extrapolation uncertainty). The UK Biobank has a well-documented healthy-volunteer bias (skewing toward higher socioeconomic status and lower disease burden than the UK general population); the true T2D rates in the general UK population of that cohort would be higher than the 6.6% overall rate observed.

2. [2] Hypertension (Geleijnse, Hofman et al.) — Long-term effects of neonatal sodium restriction on blood pressure Revisado por pares

   Long-term effects of neonatal sodium restriction on blood pressure

   Estadística

   In a randomized trial of 476 Dutch newborns (low vs normal sodium for first 6 months), the low-sodium group had 3.6 mmHg lower systolic blood pressure at 15-year follow-up (95% CI: -6.6 to -0.5)

   Extracto

   “"The adjusted systolic blood pressure at follow-up was 3.6 mm Hg lower (95% confidence interval, -6.6 to -0.5) and the diastolic pressure was 2.2 mm Hg lower (95% confidence interval, -4.5 to 0.2) in children who had been assigned to the low sodium group (n = 71) compared with the control group (n = 96). These findings suggest that sodium intake in infancy may be important in relation to blood pressure later in life." ”

   Datos de la fuente de

   1997-04-01

   Accedido

   2026-05-13 · copia archivada

   Cálculo

   Geleijnse JM, Hofman A, Witteman JC, Hazebroek AA, Valkenburg HA, Grobbee DE. Hypertension 1997;29(4):913-7. PMID 9095076. Original RCT 1980: N=476 Dutch neonates randomized to low-sodium (n=231) or normal-sodium (n=245) diet for first 6 months. 15-year follow-up retained 167 participants (35% of original N). The 3.6 mmHg lower systolic BP in the low-sodium group at age 15 is a clinically meaningful difference: a 5 mmHg reduction in systolic BP is associated with approximately 20% lower stroke risk (meta-analyses from the Blood Pressure Lowering Treatment Trialists' Collaboration). The diastolic effect (-2.2 mmHg, 95% CI: -4.5 to 0.2) was not statistically significant. The 35% follow-up retention rate is a limitation. This RCT provides the strongest experimental evidence for a lasting blood pressure effect of early-life sodium restriction, independently corroborating Gracner's observational finding on hypertension. Note: commonly misattributed as "Hofman et al. 1997" — the correct first author is Geleijnse.

3. [3] Journal of the Academy of Nutrition and Dietetics (Herrick et al., NHANES 2011-2016) — Added Sugars Intake in Infants and Toddlers Revisado por pares

   Added Sugars Intake in Infants and Toddlers

   Estadística

   60.6% of US infants aged 6-11 months consumed added sugars on a given survey day; infants averaged ~0.9 tsp/day and toddlers (12-23 mo) averaged 5.8 tsp/day of added sugars

   Extracto

   “"About 60.6% (95% CI, 55.6% to 65.4%) of infants aged 6 to 11 months and 98.3% (95% CI, 96.9% to 99.1%) of toddlers aged 12 to 23 months consumed added sugars on a given day between 2011 and 2016. On average, infants consumed almost 1 tsp (0.9 tsp, 95% CI 0.7 to 1.1 tsp) of added sugars on a given day, and toddlers consumed 5.8 tsp (95% CI, 5.3 to 6.4 tsp)." ”

   Datos de la fuente de

   2019-11-14

   Accedido

   2026-05-13 · copia archivada

   Cálculo

   Herrick KA, Fryar CD, Hamner HC, Park S, Ogden CL. J Acad Nutr Diet 2020;120(1):23-32 (published online 2019-11-14). DOI 10.1016/j.jand.2019.09.007, PMID 31735600. NHANES 2011-2016, N=1,211 US infants and toddlers aged 6-23 months (24-hour dietary recall). This study establishes that the "unrestricted early sugar" scenario is not a theoretical risk but the current reality for the majority of US infants: 60.6% already consume added sugars before age 12 months, averaging ~0.9 tsp/day (infants) and 5.8 tsp/day (toddlers). The 2017 AHA statement recommends children under 2 avoid any added sugars. This prevalence figure anchors the claim that the normalized excess-risk calculation applies to most US children, not an unusual subgroup.